| Patent Number |
Title Of Patent |
Date Issued |
| 6710046 |
Pharmaceutical composition for modulating immunity |
March 23, 2004 |
| Disclosed is a pharmaceutical composition for modulating immunity, which comprises a benzimidazole, represented by the following general formula (I), a 3H tautomer, an optically active enantiomer or a pharmaceutically acceptable acid-addition salt thereof wherein, R represents an alkyl g |
| 6703421 |
Methods of using phenylmethylbenzoquinone and hydroquinone compounds for treatment of myocarditi |
March 9, 2004 |
| A method for prevention or treating myocarditis, dilated cardiomyopathy and heart failure comprising administering to a patient in need of such treatment a NF-.kappa.B inhibitor in a therapeutically effective amount, wherein said NF-.kappa.B inhibitor is a benzoquinone derivative rep |
| 6695788 |
Methods for measurement of hemodynamics |
February 24, 2004 |
| A method for measuring hemodynamics of an experimental animal enabling repeated measurements, the method comprising the following steps:(i) ligating at least two parts of an artery, between which a part to be incised is located, of the experimental animal, the parts comprising at least o |
| 6214535 |
Method for testing cardiac myocarditis or cardiomyopathy |
April 10, 2001 |
| The present invention relates to a method for the treatment of cardiac disease resulting from a viral infection of the cardiac tissue with human hepatitis C virus or EMC virus comprising administering an antiviral agent to a subject. The antiviral agent is useful in the treatment of |
| 5827673 |
Method of detecting myocardial infarction |
October 27, 1998 |
| The present invention provides a method of detecting and diagnosing myocardial infarction which detects myocardial infarction by immunoassay using a monoclonal antibody having specific reactivity for human hepatocyte growth factor (HGF) as obtained by using human HGF as immunogen as |
| 5750551 |
Treatment for viral diseases |
May 12, 1998 |
| An angiotensin II antagonist compound is administered to mammals with viral disease. This administration ameliorates virus-associated cell injuries, producing therapeutic effects in viral diseases. This compound is also useful for the prevention of such diseases. |
| 5605919 |
Treatment for viral diseases |
February 25, 1997 |
| An angiotensin II antagonist compound is administered to mammals with viral disease. This administration ameliorates virus-associated cell injuries, producing therapeutic effects in viral diseases. This compound is also useful for the prevention of such diseases. |
| 5545623 |
Method of inhibiting secretion of inflammatory cytokines |
August 13, 1996 |
| The present invention discloses a method of inhibiting secretion of inflammatory cytokines in a host which includes administering one or more digitalis compounds in an amount effective for inhibiting secretion of an inflammatory cytokine to the host in need of inhibition of secretion of |
| 5521185 |
Methods for inhibiting graft rejection and IL-1 production |
May 28, 1996 |
| This invention provides a method of inhibiting graft rejection comprising administering a carbostyril derivative and/or its salt to a subject in need of such treatment. The method of this invention enhances the graft survival rate and can be advantageously used in the transplantation of |
